These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32624)

  • 21. Involuntary movement disorders--each has a meaning all its own.
    Kramer J; Klawans HL
    Geriatrics; 1979 Sep; 34(9):63-71. PubMed ID: 38189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Senile dyskinesias and tardive dyskinesias].
    Brion S; Plas J; Chevalier JF; Dussaux P
    Encephale; 1988 Sep; 14 Spec No():215-9. PubMed ID: 2905649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias.
    Storch A; Trenkwalder C; Oehlwein C; Winkelmann J; Polzer U; Hundemer HP; Schwarz J
    Parkinsonism Relat Disord; 2005 Sep; 11(6):393-8. PubMed ID: 15993640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Piribedil in the treatment of Parkinson disease (author's transl)].
    Nardini M; Sciannandrone R; Fieschi C; De Simone G
    Riv Patol Nerv Ment; 1975; 96(2):103-10. PubMed ID: 778998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tremor and abnormal movement in multiple sclerosis: symptomatic therapeutic indications].
    Viallet F; Witjas T; Gayraud D; Pelletier J; Regis J
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1079-84. PubMed ID: 11787340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metoprolol in the treatment of neuroleptic-induced tremor: case report.
    Chaturvedi SK
    J Clin Psychiatry; 1987 Sep; 48(9):378. PubMed ID: 2887551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inefficacy of propranolol in attenuation of drug-induced parkinsonian tremor.
    Metzer WS; Paige SR; Newton JE
    Mov Disord; 1993; 8(1):43-6. PubMed ID: 8093548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroleptic-related dyskinesias and stereotypies in autistic children: videotaped ratings.
    Shay J; Sanchez LE; Cueva JE; Armenteros JL; Overall JE; Campbell M
    Psychopharmacol Bull; 1993; 29(3):359-63. PubMed ID: 7907183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Abnormal movements induced by psychotropic drugs].
    Rondot P; Bathien N
    Encephale; 1979; 5(1):41-8. PubMed ID: 477589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Parkinsonian syndrome and post-encephalitic stereotyped involuntary movements responsive to L-dopa].
    Picard F; Hirsch E; Salmon E; Marescaux C; Collard M
    Rev Neurol (Paris); 1996 Apr; 152(4):267-71. PubMed ID: 8763655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
    Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tremor disorders of aging: diagnosis and management.
    Koller WC; Huber SJ
    Geriatrics; 1989 May; 44(5):33-6, 41. PubMed ID: 2651214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A new therapeutical approach in neurology (author's transl)].
    Divisia A; Girard-Madoux M
    Sem Hop; 1978 Nov 18-25; 54(41-42):1265-8. PubMed ID: 216105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A summary of current knowledge of tardive dyskinesia.
    Baldessarini RJ
    Encephale; 1988 Sep; 14 Spec No():263-8. PubMed ID: 2905654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [L-DOPA-induced dyskinesia].
    Derkinderen P; Vidailhet M
    Rev Neurol (Paris); 2002; 158(122):92-101. PubMed ID: 12690319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The emerging role of clozapine in the treatment of movement disorders.
    Factor SA; Friedman JH
    Mov Disord; 1997 Jul; 12(4):483-96. PubMed ID: 9251065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Long-term prognostic factors in Parkinson's disease (author's transl)].
    Guillard A; Chastang C
    Rev Neurol (Paris); 1978 May; 134(5):341-54. PubMed ID: 725403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug treatment of diseases characterized by abnormal movements.
    Marsden CD
    Proc R Soc Med; 1973 Sep; 66(9):871-3. PubMed ID: 4281483
    [No Abstract]   [Full Text] [Related]  

  • 40. Ethosuximide and tremor in Parkinson's disease: a pilot study.
    Pourcher E; Gomez-Mancilla B; Bédard PJ
    Mov Disord; 1992; 7(2):132-6. PubMed ID: 1350060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.